Vaginal Smears

Download PDF

Recent Publications on Vaginal Smears:
[Protective effect of Oviductss Ranae capsules on the reproductive organs of aged mice.] OBJECTIVE: To observe the protective effect of Oviductus Ranae (OR)...	28th June, 2008	College of Traditional Chinese Medicine, Southern Medical University,	Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):982-5.
StatBite: Percentage of women who had a pap smear in the last 3 years, 2005. The existence of a sex difference in several chronic pain syndromes and...	27th June, 2008		J Natl Cancer Inst. 2008 Jun 18;100(12):841. Epub 2008 Jun 10. DOI Direct Link
[Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions] BACKGROUND/AIM: Overexpression of p16INK4a has been found to be linked...	26th June, 2008	Vojnomedicinska akademija, Centar za patologiju i sudsku medicinu,	Vojnosanit Pregl. 2008 Mar;65(3):211-9.
Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens. CONTEXT: Although cervical cancer screening by cytology is successful, the...	25th June, 2008	James Homer Wright Pathology Laboratory, Division of Cytopathology,	Arch Pathol Lab Med. 2008 Jun;132(6):918-25.
Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up. Approximately half of women with a Papanicolaou (pap) test interpretation...	25th June, 2008	Department of Pathology, Wilford Hall Medical Center, Lackland Air Force	Ann Diagn Pathol. 2008 Jun;12(3):187-90. Epub 2008 Jan 11. DOI Direct Link
→View more research publications.

Vaginal Smears Clinical Trials:
Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide	HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale.	Breakthrough Bleeding
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive	Contraception Intervention: Drug: DR-1021
Open-Label Study to Evaluate the Efficacy and Safety of an Extended-Cycle, Low Dose Combination Oral Contraceptive	Contraception Intervention: Drug: DR-1011
Human Papilloma Virus DNA Self-Test	Papilloma Virus, Human
→View more trials.

Vaginal Smears Patents:
US Patent No.	Title
6165734	In-situ method of analyzing cells
6355670	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
6387920	Estrogen receptor modulators
6395744	Method and compositions for the treatment or amelioration of female sexual dysfunction
6403611	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Vaginal Smears scientists - we have details of around 1688 individuals working on Vaginal Smears .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.